LncRNA NORAD Promotes Vascular Endothelial Cell Injury and Atherosclerosis Through Suppressing Gene Transcription Enhancing H3K9 Deacetylation by Recruiting HDAC6

Overview

Journal Front Cell Dev Biol

Specialty Cell Biology

Date 2021 Jul 26

PMID 34307380

Citations 16

Authors

Huihua Kai

Qiyong Wu

Ruohan Yin

Xiaoqiang Tang

Haifeng Shi

Tao Wang

Ming Zhang

Changjie Pan

Affiliations

Soon will be listed here.

Abstract

Coronary artery disease (CAD) is a major atherosclerotic cardiovascular disease and the leading cause of mortality globally. Long non-coding RNAs (lncRNAs) play crucial roles in CAD development. To date, the effect of lncRNA non-coding RNA activated by DNA damage (NORAD) on atherosclerosis in CAD remains unclear. The primary aim of this study was to investigate the effect of lncRNA NORAD on vascular endothelial cell injury and atherosclerosis. Here, ox-LDL-treated human umbilical vein endothelial cells (HUVECs) and high-fat-diet (HFD)-fed ApoE mice were utilized as and models. The present study found that lncRNA NORAD expression was increased in ox-LDL-treated HUVECs and thoracic aorta of atherosclerotic mice, and knockdown of lncRNA NORAD alleviated vascular endothelial cell injury and atherosclerosis development and . Knockdown of lncRNA NORAD aggravated ox-LDL-reduced or atherosclerosis-decreased vascular endothelial growth factor (VEGF) expression in HUVECs and thoracic aorta of mice to ameliorate vascular endothelial cell injury and atherosclerosis development. Moreover, nucleus lncRNA NORAD suppressed gene transcription through enhancing H3K9 deacetylation recruiting HDAC6 to the gene promoter in ox-LDL-treated HUVECs. In addition, VEGF reduced FUS (FUS RNA binding protein) expression by a negative feedback regulation in HUVECs. In summary, lncRNA NORAD enhanced vascular endothelial cell injury and atherosclerosis through suppressing gene transcription enhancing H3K9 deacetylation by recruiting HDAC6. The findings could facilitate discovering novel diagnostic markers and therapeutic targets for CAD.

Citing Articles

Emerging Roles of Long Non-Coding RNAs in Cardiovascular Diseases.

Kong X, Li F, Wang Y J Cell Mol Med. 2025; 29(5):e70453.

PMID: 40032652 PMC: 11875779. DOI: 10.1111/jcmm.70453.

Prospective Study of lncRNA NORAD for Predicting Cerebrovascular Events in Asymptomatic Patients with Carotid Artery Stenosis.

Fan Y, Ma Y, Wang R, Wang L Clin Appl Thromb Hemost. 2025; 31():10760296241299792.

PMID: 39763215 PMC: 11705339. DOI: 10.1177/10760296241299792.

The Role of HDAC6 in Glioblastoma Multiforme: A New Avenue to Therapeutic Interventions?.

Spallotta F, Illi B Biomedicines. 2024; 12(11).

PMID: 39595195 PMC: 11591585. DOI: 10.3390/biomedicines12112631.

Elevated circulating LncRNA NORAD fosters endothelial cell growth and averts ferroptosis by modulating the miR-106a/CCND1 axis in CAD patients.

He T, Pu J, Ge H, Liu T, Lv X, Zhang Y Sci Rep. 2024; 14(1):24223.

PMID: 39414920 PMC: 11484692. DOI: 10.1038/s41598-024-76243-x.

Role of LncRNAs in the Pathogenesis of Coronary Artery Disease.

Wu X, Li J, Sun G, Yang J, Peng Y, Bai X Rev Cardiovasc Med. 2024; 24(4):96.

PMID: 39076276 PMC: 11273030. DOI: 10.31083/j.rcm2404096.

References

Munschauer M, Nguyen C, Sirokman K, Hartigan C, Hogstrom L, Engreitz J . The NORAD lncRNA assembles a topoisomerase complex critical for genome stability. Nature. 2018; 561(7721):132-136. DOI: 10.1038/s41586-018-0453-z. View

Li H, Wang X, Wen C, Huo Z, Wang W, Zhan Q . Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer. Mol Cancer. 2017; 16(1):169. PMC: 5679488. DOI: 10.1186/s12943-017-0738-0. View

Lee S, Kopp F, Chang T, Sataluri A, Chen B, Sivakumar S . Noncoding RNA NORAD Regulates Genomic Stability by Sequestering PUMILIO Proteins. Cell. 2016; 164(1-2):69-80. PMC: 4715682. DOI: 10.1016/j.cell.2015.12.017. View

Khera A, Kathiresan S . Genetics of coronary artery disease: discovery, biology and clinical translation. Nat Rev Genet. 2017; 18(6):331-344. PMC: 5935119. DOI: 10.1038/nrg.2016.160. View

Xing Y, Lai J, Liu X, Zhang N, Ming J, Liu H . Netrin-1 restores cell injury and impaired angiogenesis in vascular endothelial cells upon high glucose by PI3K/AKT-eNOS. J Mol Endocrinol. 2017; 58(4):167-177. DOI: 10.1530/JME-16-0239. View

Ross R . Atherosclerosis--an inflammatory disease. N Engl J Med. 1999; 340(2):115-26. DOI: 10.1056/NEJM199901143400207. View

Jensen H, Mehta J . Endothelial cell dysfunction as a novel therapeutic target in atherosclerosis. Expert Rev Cardiovasc Ther. 2016; 14(9):1021-33. DOI: 10.1080/14779072.2016.1207527. View

Watson G, Wickramasekara S, Fang Y, Maier C, Williams D, Dashwood R . HDAC6 activity is not required for basal autophagic flux in metastatic prostate cancer cells. Exp Biol Med (Maywood). 2015; 241(11):1177-85. PMC: 4950308. DOI: 10.1177/1535370215618518. View

Shi J, Zhang D, Zhong Z, Zhang W . lncRNA ROR promotes the progression of renal cell carcinoma through the miR‑206/VEGF axis. Mol Med Rep. 2019; 20(4):3782-3792. PMC: 6755161. DOI: 10.3892/mmr.2019.10636. View

10.

Qi H, Yao L, Liu Q . NORAD affects the progression of diabetic nephropathy through targeting miR-520h to upregulate TLR4. Biochem Biophys Res Commun. 2019; 521(1):190-195. DOI: 10.1016/j.bbrc.2019.10.102. View

11.

Ma H, Chang H, Yang W, Lu Y, Hu J, Jin S . A novel IFNα-induced long noncoding RNA negatively regulates immunosuppression by interrupting H3K27 acetylation in head and neck squamous cell carcinoma. Mol Cancer. 2020; 19(1):4. PMC: 6943933. DOI: 10.1186/s12943-019-1123-y. View

12.

Kawamura K, Higuchi T, Fujiwara S . YAF2-Mediated YY1-Sirtuin6 Interactions Responsible for Mitochondrial Downregulation in Aging Tunicates. Mol Cell Biol. 2021; 41(7):e0004721. PMC: 8224230. DOI: 10.1128/MCB.00047-21. View

13.

Ma Q, Reiter R, Chen Y . Role of melatonin in controlling angiogenesis under physiological and pathological conditions. Angiogenesis. 2019; 23(2):91-104. DOI: 10.1007/s10456-019-09689-7. View

14.

Chu C, Quinn J, Chang H . Chromatin isolation by RNA purification (ChIRP). J Vis Exp. 2012; (61). PMC: 3460573. DOI: 10.3791/3912. View

15.

Tichon A, Gil N, Lubelsky Y, Havkin Solomon T, Lemze D, Itzkovitz S . A conserved abundant cytoplasmic long noncoding RNA modulates repression by Pumilio proteins in human cells. Nat Commun. 2016; 7:12209. PMC: 4947167. DOI: 10.1038/ncomms12209. View

16.

Wu W, Li X, Zuo G, Pu J, Wu X, Chen S . The Role of Angiogenesis in Coronary Artery Disease: A Double-Edged Sword: Intraplaque Angiogenesis in Physiopathology and Therapeutic Angiogenesis for Treatment. Curr Pharm Des. 2017; 24(4):451-464. DOI: 10.2174/1381612824666171227220815. View

17.

Zhao M, Wang J, Xi X, Tan N, Zhang L . SNHG12 Promotes Angiogenesis Following Ischemic Stroke via Regulating miR-150/VEGF Pathway. Neuroscience. 2018; 390:231-240. DOI: 10.1016/j.neuroscience.2018.08.029. View

18.

Chen F, Ma X, Liu Y, Ma D, Gao X, Qian X . SIRT6 inhibits metastasis by suppressing SNAIL expression in nasopharyngeal carcinoma cells. Int J Clin Exp Pathol. 2021; 14(1):63-74. PMC: 7847487. View

19.

Amoli M, Amiri P, Alborzi A, Larijani B, Saba S, Tavakkoly-Bazzaz J . VEGF gene mRNA expression in patients with coronary artery disease. Mol Biol Rep. 2012; 39(9):8595-9. DOI: 10.1007/s11033-012-1713-x. View

20.

Ray A, Alalem M, Ray B . Loss of epigenetic Kruppel-like factor 4 histone deacetylase (KLF-4-HDAC)-mediated transcriptional suppression is crucial in increasing vascular endothelial growth factor (VEGF) expression in breast cancer. J Biol Chem. 2013; 288(38):27232-27242. PMC: 3779720. DOI: 10.1074/jbc.M113.481184. View